Tapinarof Cream 1% Once Daily for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults: The Pivotal Phase 3 ADORING Clinical Program
Authors: Lawrence F. Eichenfield, MD; Jonathan I. Silverberg, MD, PhD, MPH; Robert Bissonnette, MD; Anna M. Tallman, PharmD; Philip M. Brown, MD; David S. Rubenstein, MD, PhD; Stephen C. Piscitelli, PharmD; John E. Jett, PhD